Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónUS20110160762 A1
Tipo de publicaciónSolicitud
Número de solicitudUS 13/043,402
Fecha de publicación30 Jun 2011
Fecha de presentación8 Mar 2011
Fecha de prioridad13 May 1998
También publicado comoUS6908474, US7927347, US20020173815, US20050228432, US20100204724, WO2003077983A1
Número de publicación043402, 13043402, US 2011/0160762 A1, US 2011/160762 A1, US 20110160762 A1, US 20110160762A1, US 2011160762 A1, US 2011160762A1, US-A1-20110160762, US-A1-2011160762, US2011/0160762A1, US2011/160762A1, US20110160762 A1, US20110160762A1, US2011160762 A1, US2011160762A1
InventoresMichael Hogendijk, Juan Carlos Parodi, Mark C. Bates
Cesionario originalMichael Hogendijk, Juan Carlos Parodi, Bates Mark C
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos: USPTO, Cesión de USPTO, Espacenet
Apparatus and methods for reducing embolization during treatment of carotid artery disease
US 20110160762 A1
Resumen
Methods and apparatus are provided for removing emboli during an angioplasty, stenting or surgical procedure comprising a catheter having an occlusion element, an aspiration lumen, and a blood outlet port in communication with the lumen, a guide wire having a balloon, a venous return sheath with a blood inlet port, and tubing that couples the blood outlet port to the blood inlet port. Apparatus is also provided for occluding the external carotid artery to prevent reversal of flow into the internal carotid artery. The pressure differential between the artery and the vein provides reverse flow through the artery, thereby flushing emboli. A blood filter may optionally be included in-line with the tubing to filter emboli from blood reperfused into the patient.
Imágenes(7)
Previous page
Next page
Reclamaciones(5)
1. A method of delivering an interventional instrument for treating a stenosis in an internal carotid artery comprising:
a) inserting an occlusion mechanism having a distal occlusion member and a balloon into a person's vasculature;
b) positioning the distal occlusion member to a desired position in the common carotid artery and the balloon to a desired position in the external carotid artery; and
c) operating the distal occlusion member and the balloon to occlude the external carotid artery and the central carotid artery.
2. A method according to claim 1, wherein said occlusion mechanism further comprises a catheter having a proximal end and a distal end, an aspiration lumen extending therethrough, and said distal occlusion member positioned at said distal end of said catheter.
3. A method according to claim 2, further comprising: aspirating blood through said aspiration lumen.
4. A method according to claim 2, further comprising: inducing reverse flow to cause blood and emboli to flow into the aspiration lumen of the catheter.
5. A method according to claim 4 wherein inducing reverse flow further comprises:
a) providing a venous return sheath having a proximal end and a distal end, a lumen extending therethrough, and a blood inlet port coupled to the lumen; and
b) causing blood flow between the aspiration lumen of the catheter and the blood inlet port of the venous return sheath to induce reverse flow.
Descripción
    REFERENCE TO RELATED APPLICATIONS
  • [0001]
    The present application is a divisional of pending U.S. patent application Ser. No. 11/156,865, filed Jun. 20, 2005, which is a divisional of pending U.S. patent application of Ser. No. 10/100,630, filed Mar. 15, 2002, now U.S. Pat. No. 6,908,474, issued Jun. 21, 2005, which is a continuation-in-part of U.S. patent application Ser. No. 09/418,727, filed Oct. 15, 1999, now U.S. Pat. No. 6,423,032, issued Jul. 23, 2002, which is a continuation-in-part of U.S. patent application Ser. No. 09/333,074, filed Jun. 14, 1999, now U.S. Pat. No. 6,206,868, which is a continuation-in-part of International Application PCT/US99/05469, filed Mar. 12, 1999, which is a continuation-in-part of U.S. patent application Ser. No. 09/078,263, filed May 13, 1998, now U.S. Pat. No. 6,413,235, Issued Jul. 2, 2002.
  • FIELD OF THE INVENTION
  • [0002]
    This invention relates to apparatus and methods for protecting against embolization during vascular interventions, such as carotid artery angioplasty and endarterectomy. More particularly, the apparatus and methods of the present invention induce substantially continuous retrograde flow through the internal carotid artery during treatment during an interventional procedure, without significant blood loss.
  • BACKGROUND OF THE INVENTION
  • [0003]
    Carotid artery stenoses typically manifest in the common carotid artery, internal carotid artery or external carotid artery as a pathologic narrowing of the vascular wall, for example, caused by the deposition of plaque, that inhibits normal blood flow. Endarterectomy, an open surgical procedure, traditionally has been used to treat such stenosis of the carotid artery.
  • [0004]
    An important problem encountered in carotid artery surgery is that emboli may be formed during the course of the procedure, and these emboli can rapidly pass into the cerebral vasculature and cause ischemic stroke.
  • [0005]
    In view of the trauma and long recuperation times generally associated with open surgical procedures, considerable interest has arisen in the endovascular treatment of carotid artery stenosis. In particular, widespread interest has arisen in transforming interventional techniques developed for treating coronary artery disease, such as angioplasty and stenting, for use in the carotid arteries. Such endovascular treatments, however, are especially prone to the formation of emboli.
  • [0006]
    Such emboli may be created, for example, when an interventional instrument, such as a guide wire or angioplasty balloon, is forcefully passed into or through the stenosis, as well as after dilatation and deflation of the angioplasty balloon or stent deployment. Because such instruments are advanced into the carotid artery in the same direction as blood flow, emboli generated by operation of the instruments are carried directly to the brain by antegrade blood flow. Stroke rates after carotid artery stenting have widely varied in different clinical series, from as low as 4.4% to as high as 30%. One review of carotid artery stenting including data from twenty-four major interventional centers in Europe, North America, South America and Asia, had a combined initial failure and combined mortality/stroke rate of more than 7%. Cognitive studies and reports of intellectual changes after carotid artery stenting indicate that embolization is a common event causing subclinical cerebral damage.
  • [0007]
    Several previously known apparatus and methods attempt to remove emboli formed during endovascular procedures by trapping or suctioning the emboli out of the vessel of interest. These previously known systems, however, provide less than optimal solutions to the problems of effectively removing emboli.
  • [0008]
    Solano et al. U.S. Pat. No. 4,921,478 describes cerebral angioplasty methods and devices wherein two concentric shafts are coupled at a distal end to a distally-facing funnel-shaped structure. A lumen of the innermost shaft communicates with an opening in the funnel-shaped structure at the distal end, and is open to atmospheric pressure at the proximal end. In use, the funnel-shaped structure is deployed proximally (in the direction of flow) of a stenosis, occluding antegrade flow. An angioplasty balloon catheter is passed through the innermost lumen and into the stenosis, and then inflated to dilate the stenosis. The patent states that when the angioplasty balloon is deflated, a pressure differential between atmospheric pressure and the blood distal to the angioplasty balloon causes a reversal of flow in the vessel that flushes any emboli created by the angioplasty balloon through the lumen of the innermost catheter.
  • [0009]
    While a seemingly elegant solution to the problem of emboli removal, several drawbacks of the device and methods described in the Solano et al. patent seem to have lead to abandonment of that approach. Chief among these problems is the inability of that system to generate flow reversal during placement of the guide wire and the angioplasty balloon across the stenosis. Because flow reversal does not occur until after deflation of the angioplasty balloon, there is a substantial risk that any emboli created during placement of the angioplasty balloon will travel too far downstream to be captured by the subsequent flow reversal. It is expected that this problem is further compounded because only a relatively small volume of blood is removed by the pressure differential induced after deflation of the angioplasty balloon.
  • [0010]
    Applicant has determined another drawback of the method described in the Solano patent: deployment of the funnel-shaped structure in the common carotid artery (“CCA”) causes reversal of flow from the external carotid artery (“ECA”) into the internal carotid artery (“ICA”). Consequently, when a guide wire or interventional instrument is passed across a lesion in either the ECA or ICA, emboli dislodged from the stenosis are introduced into the blood flow and carried into the cerebral vasculature via the ICA.
  • [0011]
    The insufficient flow drawback identified for the system of the Solano patent is believed to have prevented development of a commercial embodiment of the similar system described in EP Publication No. 0 427 429. EP Publication No. 0 427 429 describes use of a separate balloon to occlude the ECA prior to crossing the lesion in the ICA. However, like Solano, that publication discloses that flow reversal occurs only when the dilatation balloon in the ICA is deflated.
  • [0012]
    Chapter 46 of Interventional Neuroradiology: strategies and practical techniques (J. J. Connors & J. Wojak, 1999), published by Saunders of Philadelphia, Pa., describes using a coaxial balloon angioplasty system for patients having proximal ICA stenoses. In particular, a small, deflated occlusion balloon on a wire is introduced into the origin of the ECA, and a guide catheter with a deflated occlusion balloon is positioned in the CCA just proximal to the origin of the ECA. A dilation catheter is advanced through a lumen of the guide catheter and dilated to disrupt the stenosis. Before deflation of the dilation catheter, the occlusion balloons on the guide catheter and in the ECA are inflated to block antegrade blood flow to the brain. The dilation balloon then is deflated, the dilation catheter is removed, and blood is aspirated from the ICA to remove emboli.
  • [0013]
    Applicant has determined that cerebral damage still may result from the foregoing previously known procedure, which is similar to that described in EP Publication No. 0 427 429, except that the ICA is occluded prior to the ECA. Consequently, both of these previously known systems and methods suffer from the same drawback—the inability to generate flow reversal at sufficiently high volumes during placement of the guide wire and dilation catheter across the stenosis. Both methods entail a substantial risk that any emboli created during placement of the balloon will travel too far downstream to be captured by the flow reversal.
  • [0014]
    Applicants note, irrespective of the method of aspiration employed with the method described in the foregoing Interventional Neuroradioloqy article, substantial drawbacks are attendant. If, for example, natural aspiration is used (i.e., induced by the pressure gradient between the atmosphere and the artery), then only a relatively small volume of blood is expected to be removed by the pressure differential induced after deflation of the angioplasty balloon. If, on the other hand, an external pump is utilized, retrieval of these downstream emboli may require a flow rate that cannot be sustained for more than a few seconds, resulting insufficient removal of emboli.
  • [0015]
    Furthermore, with the dilation balloon in position, the occlusion balloons are not inflated until after inflation of the dilation balloon. Microemboli generated during advancement of the dilation catheter into the stenosed segment may therefore be carried by antegrade blood flow into the brain before dilation, occlusion, and aspiration are even attempted.
  • [0016]
    Imran U.S. Pat. No. 5,833,650 describes a system for treating stenoses that comprises three concentric shafts. The outermost shaft includes a proximal balloon at its distal end that is deployed proximal of a stenosis to occlude antegrade blood flow. A suction pump then draws suction through a lumen in the outermost shaft to cause a reversal of flow in the vessel while the innermost shaft is passed across the stenosis. Once located distal to the stenosis, a distal balloon on the innermost shaft is deployed to occlude flow distal to the stenosis. Autologous blood taken from a femoral artery using an extracorporeal blood pump is infused through a central lumen of the innermost catheter to provide continued antegrade blood flow distal to the distal balloon. The third concentric shaft, which includes an angioplasty balloon, is then advanced through the annulus between the innermost and outermost catheters to dilate the stenosis.
  • [0017]
    Like the device of the Solano patent, the device of the Imran patent appears to suffer the drawback of potentially dislodging emboli that are carried into the cerebral vasculature. In particular, once the distal balloon of Imran's innermost shaft is deployed, flow reversal in the vasculature distal to the distal balloon ceases, and the blood perfused through the central lumen of the innermost shaft establishes antegrade flow. Importantly, if emboli are generated during deployment of the distal balloon, those emboli will be carried by the perfused blood directly into the cerebral vasculature, and again pose a risk of ischemic stroke. Moreover, there is some evidence that reperfusion of blood under pressure through a small diameter catheter may contribute to hemolysis and possible dislodgment of emboli.
  • [0018]
    In applicant's co-pending U.S. patent application Ser. No. 09/333,074, filed Jun. 14, 1999, which is incorporated herein by reference, applicant described the use of external suction to induce regional reversal of flow. That application further described that intermittently induced regional flow reversal overcomes the drawbacks of naturally-aspirated systems such as described hereinabove. However, the use of external suction may in some instances result in flow rates that are too high to be sustained for more than a few seconds. In addition, continuous use of an external pump may result in excessive blood loss, requiring infusion of non-autologous blood and/or saline that causes hemodilution, reduced blood pressure, or raise related safety issues.
  • [0019]
    In view of these drawbacks of the previously known emboli removal systems, it would be desirable to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that reduce the risk that emboli are carried into the cerebral vasculature.
  • [0020]
    It also would be desirable to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that provide substantially continuous retrograde blood flow from the treatment zone, thereby reducing the risk that emboli are carried into the cerebral vasculature.
  • [0021]
    It further would be desirable to provide emboli removal methods and apparatus that prevent the development of reverse flow from the ECA and antegrade into the ICA once the CCA has been occluded, thereby enhancing the likelihood that emboli generated by a surgical or interventional procedure are effectively removed from the vessel.
  • [0022]
    It also would be desirable to provide methods and apparatus that allow for placement of an interventional device so that retrograde flow may be achieved in the treatment vessel prior to having a guide wire cross the lesion.
  • [0023]
    It also would be desirable to provide methods and apparatus for removing emboli during an angioplasty or carotid stenting procedure that enable filtering of emboli and reduced blood loss.
  • SUMMARY OF THE INVENTION
  • [0024]
    In view of the foregoing, it is an object of this invention to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that reduce the risk that emboli are carried into the cerebral vasculature.
  • [0025]
    It also is an object of the present invention to provide methods and apparatus for removing emboli from within the carotid arteries during interventional procedures, such as angioplasty or carotid stenting, that provide substantially continuous retrograde blood flow from the treatment zone, thereby reducing the risk that emboli are carried into the cerebral vasculature.
  • [0026]
    It is another object of the present invention to provide emboli removal methods and apparatus that prevent the development of reverse flow between the ECA and ICA once the common carotid artery has been occluded, thereby enhancing the likelihood that emboli generated by a surgical or interventional procedure are effectively removed from the vessel.
  • [0027]
    It is still a further object of the present to provide methods and apparatus that allow for placement of an interventional device so that retrograde flow may be achieved in the treatment vessel prior to having a guide wire cross the lesion.
  • [0028]
    It is yet another object of the present invention to provide methods and apparatus for removing emboli during an angioplasty or carotid stenting procedure that enable filtering of emboli and reduced blood loss.
  • [0029]
    The foregoing objects of the present invention are accomplished by providing interventional apparatus comprising an arterial catheter, an occlusion element disposed on a guide wire, a venous return sheath, and optionally a blood filter. The arterial catheter has proximal and distal ends, an aspiration lumen extending therethrough, an occlusion element disposed on the distal end, and a hemostatic port and blood outlet port disposed on the proximal end that communicate with the aspiration lumen. The aspiration lumen is sized so that an interventional instrument, e.g., an angioplasty catheter or stent delivery system, may be readily advanced therethrough to the site of a stenosis in either the ECA (proximal to the occlusion element) or the ICA.
  • [0030]
    In accordance with the principles of the present invention, the arterial catheter is disposed in the CCA proximal of the ICA/ECA bifurcation, the occlusion element on the guide wire is disposed in the ECA to occlude flow reversal from the ECA to the ICA, and the blood outlet port of the arterial catheter is coupled to the venous return sheath, with or without the blood filter disposed therebetween. Higher arterial than venous pressure, especially during diastole, permits substantially continuous flow reversal in the ICA during the procedure (other than when a dilatation balloon is inflated), thereby flushing blood containing emboli from the vessel. The blood is filtered and reperfused into the body through the venous return sheath.
  • [0031]
    In an alternative embodiment, the occlusion element disposed on the guide wire may be omitted, and replaced with apparatus comprising a self-expanding element having proximal and distal ends, a retrieval wire coupled to the proximal end and an atraumatic tip coupled to the distal end. In this embodiment, a dilator having a lumen may be disposed within the aspiration lumen of the catheter so that the occlusion element is provided in a contracted state within the lumen of the dilator. The occlusion element then is ejected from the dilator and self-expands to occlude the ECA. The dilator then is removed from the aspiration lumen of the catheter, and the distal end of the catheter is re-positioned in the CCA proximal of the carotid bifurcation. Flow reversal is induced in the ICA, as described above, and the self-expanding occlusion element may be contracted using the retrieval wire provided.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0032]
    Further features of the invention, its nature and various advantages will be more apparent from the accompanying drawings and the following detailed description of the preferred embodiments, in which:
  • [0033]
    FIGS. 1A and 1B are schematic views of previously known emboli protection systems;
  • [0034]
    FIG. 2 is a schematic view of an emboli protection system in accordance with principles of the present invention;
  • [0035]
    FIGS. 3A-3D are, respectively, a schematic view of apparatus in accordance with a first embodiment of the present invention, detailed side and sectional views of the distal end of an interventional device of the present invention, and a cross-sectional view of an interventional device of the present invention;
  • [0036]
    FIGS. 4A and 4B are views of the distal end of an alternative interventional device suitable for use in the system of the present invention;
  • [0037]
    FIGS. 5A-5D illustrate a method of using the system of FIG. 3 in accordance with the principles of the present invention;
  • [0038]
    FIGS. 6A-6C are, respectively, a schematic view and cross-sectional views of the proximal and distal ends of a catheter of an alternative embodiment of the present invention;
  • [0039]
    FIGS. 7A-7B depict features of the self-expanding occlusion element of FIG. 6; and
  • [0040]
    FIGS. 8A-8D illustrate a method of using the system of FIG. 6 in accordance with the principles of the present invention.
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0041]
    Referring to FIGS. 1A and 1B, drawbacks of previously known emboli removal catheters are described with reference to performing percutaneous angioplasty of stenosis S in common carotid artery CCA.
  • [0042]
    With respect to FIG. 1A, drawbacks associated with naturally-aspirated emboli removal systems, such as described in the above-mentioned patent to Solano and European Patent Publication, are described. No flow reversal is induced by those systems until after balloon 10 of angioplasty catheter 11 first is passed across the stenosis, inflated, and then deflated. However, applicant has determined that once member 15 of emboli removal catheter 16 is inflated, flow within the ECA reverses and provides antegrade flow into the ICA, due to the lower hemodynamic resistance of the ICA. Consequently, emboli E generated while passing guide wire 20 or catheter 11 across stenosis S may be carried irretrievably into the cerebral vasculature, before flow in the vessel is reversed and directed into the aspiration lumen of emboli removal catheter 16 by opening the proximal end of the aspiration lumen to atmospheric pressure. Furthermore, natural-aspiration may not remove an adequate volume of blood to retrieve even those emboli that have not yet been carried all the way into the cerebral vasculature.
  • [0043]
    In FIG. 1B, system 17 described in the above-mentioned patent to Imran is shown. As described hereinabove, deployment of distal balloon 18, and ejection of blood out of the distal end of the inner catheter, may dislodge emboli from the vessel wall distal to balloon 18. The introduction of antegrade flow through inner catheter 19 is expected only to exacerbate the problem by pushing the emboli further into the cerebral vasculature. Thus, while the use of positive suction in the Imran system may remove emboli located in the confined treatment field defined by the proximal and distal balloons, such suction is not expected to provide any benefit for emboli dislodged distal of distal balloon 18.
  • [0044]
    Referring now to FIG. 2, apparatus and methods in accordance with the present invention are described. Apparatus 30 comprises catheter 31 having an aspiration lumen and occlusion element 32, and guide wire 35 having inflatable balloon 36 disposed on its distal end. In accordance with the principles of the present invention, antegrade blood flow is stopped when both occlusion element 32 in the CCA and inflatable balloon 36 are deployed. Furthermore, the aspiration lumen of catheter 31 is connected to a venous return sheath (described hereinbelow), disposed, for example, in the patient's femoral vein. In this manner a substantially continuous flow of blood is induced between the treatment site and the patient's venous vasculature. Because flow through the artery is towards catheter 31, any emboli dislodged by advancing a guide wire or angioplasty catheter 33 across stenosis S causes the emboli to be aspirated by catheter 31.
  • [0045]
    Unlike the previously known naturally-aspirated systems, the present invention provides substantially continuous retrograde blood flow through the ICA while preventing blood from flowing retrograde in the ECA and antegrade into the ICA, thereby preventing emboli from being carried into the cerebral vasculature. Because the apparatus and methods of the present invention “recycle” emboli-laden blood from the arterial catheter through the blood filter and to the venous return sheath, the patient experiences significantly less blood loss.
  • [0046]
    Referring now to FIG. 3A, embolic protection apparatus 40 constructed in accordance with the principles of the present invention is described. Apparatus 40 comprises arterial catheter 41, guide wire 45, venous return sheath 52, tubing 49 and optional blood filter 50.
  • [0047]
    Catheter 41 includes distal occlusion element 42, proximal hemostatic port 43, e.g., a Touhy-Borst connector, inflation port 44, and blood outlet port 48. Guide wire 45 includes balloon 46 that is inflated via inflation port 47. Tubing 49 couples blood outlet port 48 to filter 50 and blood inlet port 51 of venous return sheath 52.
  • [0048]
    Guide wire 45 and balloon 46 are configured to pass through hemostatic port 43 and the aspiration lumen of catheter 41 (see FIGS. 3C and 3D), so that the balloon may be advanced into and occlude the ECA. Port 43 and the aspiration lumen of catheter 41 are sized to permit additional interventional devices, such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced through the aspiration lumen when guide wire 45 is deployed.
  • [0049]
    Guide wire 45 preferably comprises a small diameter flexible shaft having an inflation lumen that couples inflatable balloon 46 to inflation port 47.
  • [0050]
    Inflatable balloon 46 preferably comprises a compliant material, such as described hereinbelow with respect to occlusion element 42 of emboli removal catheter 41.
  • [0051]
    Venous return sheath 52 includes hemostatic port 53, blood inlet port 51 and a lumen that communicates with ports 53 and 51 and tip 54.
  • [0052]
    Venous return sheath 52 may be constructed in a manner per se known for venous introducer catheters. Tubing 49 may comprise a suitable length of a biocompatible material, such as silicone. Alternatively, tubing 49 may be omitted and blood outlet port 48 of catheter 41 and blood inlet port 51 of venous return sheath 52 may be lengthened to engage either end of filter 50 or each other.
  • [0053]
    With respect to FIGS. 3B and 3C, distal occlusion element 42 comprises expandable bell or pear-shaped balloon 55. In accordance with manufacturing techniques that are known in the art, balloon 55 comprises a compliant material, such as polyurethane, latex or polyisoprene which has variable thickness along its length to provide a bell-shape when inflated. Balloon 55 is affixed to distal end 56 of catheter 41, for example, by gluing or a melt-bond, so that opening 57 in balloon 55 leads into aspiration lumen 58 of catheter 41. Balloon 55 preferably is wrapped and heat treated during manufacture so that distal portion 59 of the balloon extends beyond the distal end of catheter 41 and provides an atraumatic tip or bumper for the catheter.
  • [0054]
    As shown in FIG. 3D, catheter 41 preferably comprises inner layer 60 of low-friction material, such as polytetrafluoroethylene (“PTFE”), covered with a layer of flat stainless steel wire braid 61 and polymer cover 62 (e.g., polyurethane, polyethylene, or PEBAX). Inflation lumen 63 is disposed within polymer cover 62 and couples inflation port 44 to balloon 55. In a preferred embodiment of catheter 41, the diameter of lumen 58 is about 7 Fr, and the outer diameter of the catheter is about 9 Fr.
  • [0055]
    Referring now to FIGS. 4A and 4B, an alternative embodiment of occlusion element 42 of the system of FIG. 3A is described. In FIGS. 4A and 4B, occlusion element 42 of emboli removal catheter 41 comprises self-expanding wire basket 65 covered with elastomeric polymer 66, such as latex, polyurethane or polyisoprene. Alternatively, a tightly knit self-expanding wire mesh may be used, with or without an elastomeric covering.
  • [0056]
    Catheter 41 is contained within movable sheath 67. Catheter 41 is inserted transluminally with sheath 67 in a distalmost position, and after basket 65 has been determined to be in a desired position proximal to a stenosis, sheath 67 is retracted proximally to cause basket 65 to deploy. Upon completion of the procedure, basket 65 is again collapsed within sheath 67 by moving the sheath to its distalmost position. Operation of the system of FIG. 3A using the emboli removal catheter of FIGS. 4A and 4B is similar to that described hereinbelow for FIGS. 5A-5D, except that the occlusion element self-expands when sheath 67 is retracted, rather than by infusing an inflation medium to balloon 55.
  • [0057]
    Referring now to FIGS. 5A-5D, use of the apparatus of FIG. 3 in accordance with the methods of the present invention is described. In FIG. 5, stenosis S is located in internal carotid artery ICA above the bifurcation between the ICA and the external carotid artery ECA. In a first step, guide wire 80 is inserted into a patient's arterial vasculature and a distal end of guide wire 80 preferably is disposed just proximal of the carotid bifurcation, as shown in FIG. 5A. A dilator (not shown), which is disposed within catheter 41, then may be inserted over guide wire 80 to advance catheter 41 to a position proximal of stenosis S, as shown in FIG. 5A, and the dilator may be removed. Balloon 55 of distal occlusion element 42 then is inflated via inflation port 44, preferably using a radiopaque contrast solution, and guide wire 80 may be removed. Once balloon 55 of distal occlusion element 42 is inflated, flow within the ECA reverses and provides antegrade flow into the ICA, as shown in FIG. 5A, due to the lower hemodynamic resistance of the ICA.
  • [0058]
    Venous return sheath 52 then is introduced into the patient's femoral vein, either percutaneously or via a surgical cut-down. Filter 50 then is coupled between blood outlet port 48 of catheter 41 and blood inlet port 51 of venous return sheath 52 using tubing 49, and any air is removed from the line. Once this circuit is closed, negative pressure in the venous sheath during diastole will establish a low rate continuous flow of blood through aspiration lumen 58 of catheter 41, to the patient's vein via venous return sheath 52.
  • [0059]
    Guide wire 45 and balloon 46 then may be advanced through aspiration lumen 58. When balloon 46 is disposed within the ECA, as determined, e.g., using a fluoroscope and a radiopaque inflation medium injected into balloon 46, balloon 46 is inflated. The deployment of balloon 46 in the ECA, in conjunction with the negative pressure in the venous sheath during diastole, will established a retrograde flow dynamic in the ICA, as shown in FIG. 5B.
  • [0060]
    This continuous retrograde flow in the ICA due to the difference between venous pressure and arterial pressure will continue throughout the interventional procedure. Specifically, blood passes through aspiration lumen 58 and blood outlet port 48 of catheter 41, through biocompatible tubing 49 to filter 50, and into blood inlet port 51 of venous return sheath 52, where it is reperfused into the remote vein. Filtered emboli collect in filter 50 and may be studied and characterized upon completion of the procedure.
  • [0061]
    Continuous blood flow (except during inflation of any dilatation instruments) with reperfusion in accordance with the present invention provides efficient emboli removal with significantly reduced blood loss. Alternatively, filter 50 may be omitted, in which case emboli removed from the arterial side will be introduced into the venous side, and eventually captured in the lungs. Because of a low incidence of septal defects, which could permit such emboli to cross-over to the left ventricle, the use of filter 50 is preferred.
  • [0062]
    Referring to FIG. 5C, an interventional instrument, such as conventional angioplasty balloon catheter 71 having balloon 72, is loaded through hemostatic port 43 and aspiration lumen 58 and positioned within the stenosis, preferably via guide wire 73. Hemostatic port 43 is closed and instrument 71 is actuated to disrupt the plaque forming stenosis S.
  • [0063]
    As seen in FIG. 5D, upon completion of the angioplasty portion of the procedure using catheter 71, balloon 72 is deflated. Throughout the procedure, except when the dilatation balloon is fully inflated, the pressure differential between the blood in the ICA and the venous pressure causes blood in the ICA to flow in a retrograde direction into aspiration lumen 58 of emboli removal catheter 41, thereby flushing any emboli from the vessel. The blood is filtered and reperfused into the patient's vein.
  • [0064]
    As set forth above, the method of the present invention protects against embolization, first, by preventing the reversal of blood flow from the ECA to the ICA when distal occlusion element 42 is inflated, and second, by providing continuous, low volume blood flow from the carotid artery to the remote vein in order to filter and flush any emboli from the vessel and blood stream. Advantageously, the method of the present invention permits emboli to be removed with little blood loss, because the blood is filtered and reperfused into the patient. Furthermore, continuous removal of blood containing emboli prevents emboli from migrating too far downstream for aspiration.
  • [0065]
    Referring now to FIG. 6, apparatus 240 constructed in accordance with the present invention is described. Apparatus 240 is an alternative embodiment of apparatus 40 described hereinabove and comprises arterial catheter 241 having proximal and distal ends, distal occlusion element 242 disposed on the distal end, proximal hemostatic port 243, inflation port 244 and blood outlet port 248. Self-expanding occlusion element 246 having proximal and distal ends preferably comprises non-expanding occlusion base 256 disposed at the proximal end, wherein occlusion base 256 comprises proximal taper 269. Occlusion element 246 is coupled to retrieval wire 247 at the proximal end and atraumatic tip 245 at the distal end, e.g., by affixing retrieval wire 247 to proximal taper 269 of occlusion base 256 and affixing atraumatic tip 245 to a distal end of occlusion base 256, as shown in FIG. 6A. Biocompatible tubing 249 couples blood outlet port 248 to filter 250 and to blood inlet port 251 of venous return sheath 252. Arterial catheter 241, venous return sheath 252 and tubing 249 are constructed as described hereinabove, except as noted below.
  • [0066]
    Catheter 241 comprises aspiration lumen 258, as shown in FIG. 6B, which is sized to permit interventional devices, such as angioplasty balloon catheters, atherectomy devices and stent delivery systems to be advanced through port 243 and the aspiration lumen. Retrieval wire lumen 264 is sized to permit longitudinal movement of retrieval wire 247 of occlusion element 246. Retrieval wire lumen 264 spans from the proximal end of catheter 241 to a location just proximal of the distal end, e.g., about 1 to 2 cm proximal of the distal end of catheter 241. At this location, retrieval wire lumen 264 merges with aspiration lumen 258 to form channel 265, as shown in FIG. 6C.
  • [0067]
    Referring to FIG. 7, deployment of occlusion element 246 is described. Occlusion element 246 initially is provided in a contracted state, as shown in FIG. 7A. In the contracted state, occlusion element 246 is disposed within a lumen of dilator 270, which in turn is disposed within aspiration lumen 258 of catheter 241. Dilator 270 comprises proximal and distal ends, with occlusion element 246 being positioned within a slot in the distal end. The distal end of dilator 270 tapers and extends distal to catheter 241, as shown in FIG. 7A. Atraumatic tip 245 of occlusion element 246 extends distal to dilator 270 and facilitates guidance of the device through a patient's vasculature.
  • [0068]
    Push member 272 having proximal and distal ends is configured for longitudinal movement within the lumen of dilator 270. During delivery of catheter 241, the distal end of push member 272 preferably abuts occlusion base 256 of occlusion element 246, while the proximal end of push member 272 may be manipulated by a physician. Dilator 270 comprises slot 271 disposed at the distal end. Slot 271 allows retrieval wire 247 to extend from a distal point in which it is coupled to occlusion base 256, to a proximal point in which it enters retrieval wire lumen 264, as shown in FIG. 7A.
  • [0069]
    Upon positioning the distal end of catheter 241 at a selected location, push member 272 is held stationary while dilator 270 is retracted proximally, so that occlusion element 246 effectively is no longer constrained within the lumen of dilator 270. This causes occlusion element 246 to self-expand to a predetermined shape, as shown in FIG. 7B. Occlusion element 246 is sized to occlude flow in the external carotid artery in this deployed state.
  • [0070]
    Dilator slot 271 allows retrieval wire 247 to move freely during the deployment of occlusion element 246. After deployment of occlusion element 246, dilator 270 and push member 272 are removed from within aspiration lumen 258, as shown in FIG. 7B. Catheter 241 then may be positioned separately from occlusion element 246, as described hereinbelow with respect to FIG. 8, and may be used to deliver other interventional apparatus, such as angioplasty catheters or stent delivery systems.
  • [0071]
    At the completion of the interventional procedure, occlusion element 246 is contracted by proximally retracting retrieval wire 247. Occlusion element 246 is retrieved when the proximal load exerted on retrieval wire 247 exceeds the frictional forces between occlusion element 246 and the external carotid artery wall. After occlusion element 246 is contracted, occlusion base 256, occlusion element 246 and atraumatic tip 245 may be retracted partially or fully into aspiration lumen 258. Channel 265 of FIG. 6C may be used to provide a transition at the distal end of catheter 241 so that occlusion element 246 is effectively guided into aspiration lumen 258 when retrieval wire 247 is retracted proximally. In effect, this allows occlusion element 246 to be contained within at least a distal portion of catheter 241, to allow for safe removal of catheter 241.
  • [0072]
    Referring to FIG. 8, method steps for using the apparatus of FIGS. 6-7 to treat carotid artery disease is provided. In FIG. 8, stenosis S is located in the ICA above the carotid bifurcation. In a first step, catheter 241 is inserted, either percutaneously and transluminally or via a surgical cut-down, to a position proximal of stenosis S. Occlusion element 246 is disposed within a lumen at the distal end of dilator 270, as described in FIG. 7A, and atraumatic tip 245 is used to guide catheter 241. The distal end of catheter 241 preferably is positioned within the ECA, as shown in FIG. 8A, so that occlusion element 246 will be deployed into the ECA.
  • [0073]
    Push member 272 of FIG. 7A then is held stationary while dilator 270 is retracted proximally, so that occlusion element 246 is no longer constrained by dilator 270. Occlusion element 246 then self-expands to occlude flow in the ECA, as shown in FIG. 8B. Dilator 270 and push member 272 then are removed from within aspiration lumen 258, and catheter 241 is retracted to a location just proximal of the carotid bifurcation, as shown in FIG. 8B. Distal occlusion element 242 of catheter 241 then may be inflated via inflation port 244 to occlude antegrade flow in the CCA.
  • [0074]
    Venous return sheath 252 may be introduced into the patient's femoral vein, either percutaneously or via a surgical cut-down, and filter 250 may be coupled between blood outlet port 248 of catheter 241 and blood inlet port 251 of venous return sheath 252 using tubing 249. Once this circuit is closed, negative pressure in the venous sheath establishes a continuous retrograde flow of blood through aspiration lumen 258 of catheter 241, as shown in FIG. 8B, to the patient's vein via venous return sheath 252. Alternatively, venous return sheath 252 may be omitted, and the proximal end of catheter 241 connected to a receptacle to collect blood aspirated through aspiration lumen 258.
  • [0075]
    Referring to FIG. 8C, with distal occlusion element 242 inflated and a retrograde flow established in the ICA, an interventional instrument, such as conventional angioplasty balloon catheter 281 having balloon 282, is loaded through hemostatic port 243 and aspiration lumen 258 and positioned within stenosis S, preferably via guide wire 283. Hemostatic port 243 is closed and instrument 281 is actuated to disrupt stenosis S.
  • [0076]
    As shown in FIG. 8D, upon completion of the angioplasty portion of the procedure using catheter 281, balloon 282 is deflated. Throughout the procedure, except when the dilatation balloon is fully inflated, the pressure differential between the blood in the ICA and the venous pressure causes blood in the ICA to flow in a retrograde direction and into aspiration lumen 258 of emboli removal catheter 241, thereby flushing any emboli E from the vessel. Upon satisfactory removal of emboli, occlusion element 246 is contracted by proximally retracting retrieval wire 247. Occlusion element 246 still further may be contracted when it contacts the distal end of catheter 241. When occlusion element 246 has been contracted, it then may be retracted either partially or fully into aspiration lumen 258 of catheter 241 via channel 265. Distal occlusion element 242 of catheter 241 then is deflated and the apparatus is removed from the patient's vessel.
  • [0077]
    While preferred illustrative embodiments of the invention are described above, it will be apparent to one skilled in the art that various changes and modifications may be made. The appended claims are intended to cover all such changes and modifications that fall within the true spirit and scope of the invention.
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
US2687131 *17 Sep 195224 Ago 1954Davol Rubber CoFemale incontinence catheter
US3634924 *20 Abr 197018 Ene 1972American Hospital Supply CorpMethod of making multilumen balloon catheter
US3831587 *8 Feb 197327 Ago 1974Mc Anally RMultipurpose vaginal and cervical device
US3889685 *2 Nov 197317 Jun 1975Cutter LabTubular unit with vessel engaging cuff structure
US4014206 *31 Mar 197529 Mar 1977Akron City HospitalApparatus and method for monitoring air emboli during extracorporeal circulation
US4451256 *28 Abr 198229 May 1984Intermedicat GmbhCatheter set
US4571240 *12 Ago 198318 Feb 1986Advanced Cardiovascular Systems, Inc.Catheter having encapsulated tip marker
US4575371 *16 Abr 198211 Mar 1986Percy NordqvistUrinary catheter
US4577631 *16 Nov 198425 Mar 1986Kreamer Jeffry WAneurysm repair apparatus and method
US4781681 *15 Sep 19871 Nov 1988Gv Medical, Inc.Inflatable tip for laser catheterization
US4794928 *10 Jun 19873 Ene 1989Kletschka Harold DAngioplasty device and method of using the same
US4820270 *6 Ago 198711 Abr 1989David HardcastleBalloon catheter and process for the manufacture thereof
US4917667 *9 Ene 198917 Abr 1990Retroperfusion Systems, Inc.Retroperfusion balloon catheter and method
US4921478 *23 Feb 19881 May 1990C. R. Bard, Inc.Cerebral balloon angioplasty system
US5011488 *20 Ago 199030 Abr 1991Robert GinsburgThrombus extraction system
US5030227 *1 Jun 19899 Jul 1991Advanced Surgical Intervention, Inc.Balloon dilation catheter
US5071407 *12 Abr 199010 Dic 1991Schneider (U.S.A.) Inc.Radially expandable fixation member
US5074845 *27 Mar 199124 Dic 1991Baxter International Inc.Catheter with heat-fused balloon with waist
US5102415 *30 Ago 19907 Abr 1992Guenther Rolf WApparatus for removing blood clots from arteries and veins
US5141494 *15 Feb 199025 Ago 1992Danforth Biomedical, Inc.Variable wire diameter angioplasty dilatation balloon catheter
US5171305 *17 Oct 199115 Dic 1992Imagyn Medical, Inc.Linear eversion catheter with reinforced inner body extension
US5195980 *3 Ene 199223 Mar 1993Thomas Medical Products, Inc.Hemostatic valve
US5221261 *10 Ago 199222 Jun 1993Schneider (Usa) Inc.Radially expandable fixation member
US5358472 *9 Sep 199325 Oct 1994Schneider (Usa) Inc.Guidewire atherectomy catheter and method of using the same
US5370618 *20 Nov 19926 Dic 1994World Medical Manufacturing CorporationPulmonary artery polyurethane balloon catheter
US5439446 *30 Jun 19948 Ago 1995Boston Scientific CorporationStent and therapeutic delivery system
US5441485 *24 Feb 199415 Ago 1995Peters; Michael J.Bladder catheter
US5465259 *12 Ago 19937 Nov 1995Fujitsu LimitedLSI system with a plurality of LSIs having different scan systems and provided on a printed circuit board
US5478309 *27 May 199426 Dic 1995William P. Sweezer, Jr.Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery
US5484412 *19 Abr 199416 Ene 1996Pierpont; Brien E.Angioplasty method and means for performing angioplasty
US5499975 *17 Dic 199319 Mar 1996Cook IncorporatedSmooth transitioned dilator-sheath assembly and method
US5522882 *21 Oct 19944 Jun 1996Impra, Inc.Method and apparatus for balloon expandable stent-graft delivery
US5527292 *9 Sep 199418 Jun 1996Scimed Life Systems, Inc.Intravascular device for coronary heart treatment
US5549626 *23 Dic 199427 Ago 1996New York Society For The Ruptured And Crippled Maintaining The Hospital For Special SurgeryVena caval filter
US5558644 *12 Ene 199524 Sep 1996Heartport, Inc.Retrograde delivery catheter and method for inducing cardioplegic arrest
US5569204 *20 Jun 199429 Oct 1996Schneider (Europe) A.G.Aspiration catheter arrangement
US5584803 *28 Jul 199417 Dic 1996Heartport, Inc.System for cardiac procedures
US5601581 *19 May 199511 Feb 1997General Surgical Innovations, Inc.Methods and devices for blood vessel harvesting
US5601591 *23 Sep 199411 Feb 1997Vidamed, Inc.Stent for use in prostatic urethra, apparatus and placement device for same and method
US5639274 *2 Jun 199517 Jun 1997Fischell; Robert E.Integrated catheter system for balloon angioplasty and stent delivery
US5653689 *30 Sep 19955 Ago 1997Abacus Design & Development, Inc.Infusion catheter
US5669924 *26 Oct 199523 Sep 1997Shaknovich; AlexanderY-shuttle stent assembly for bifurcating vessels and method of using the same
US5669927 *24 Oct 199523 Sep 1997Richard Wolf GmbhInstrument for morcellating
US5702373 *31 Ago 199530 Dic 1997Target Therapeutics, Inc.Composite super-elastic alloy braid reinforced catheter
US5738652 *17 Ene 199714 Abr 1998Heartport, Inc.Retrograde delivery catheter and method for inducing cardioplegic arrest
US5765568 *1 Dic 199516 Jun 1998Heartport, Inc.Catheter system and method for venting the left ventricle
US5766151 *7 Jun 199516 Jun 1998Heartport, Inc.Endovascular system for arresting the heart
US5766203 *10 Oct 199616 Jun 1998Intelliwire, Inc.Sheath with expandable distal extremity and balloon catheters and stents for use therewith and method
US5794629 *27 Nov 199618 Ago 1998The Regents Of The University Of CaliforniaMethod for treating ischemic brain stroke
US5800375 *20 Dic 19951 Sep 1998Heartport, Inc.Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery
US5807326 *6 Mar 199515 Sep 1998Minnesota Mining And Manufacturing CompanyRetrograde coronary sinus catheter
US5810757 *1 Dic 199522 Sep 1998Heartport, Inc.Catheter system and method for total isolation of the heart
US5814016 *7 Feb 199729 Sep 1998Heartport, Inc.Endovascular system for arresting the heart
US5833650 *5 Jun 199510 Nov 1998Percusurge, Inc.Catheter apparatus and method for treating occluded vessels
US5843027 *4 Dic 19961 Dic 1998Cardiovascular Dynamics, Inc.Balloon sheath
US5895399 *9 Oct 199620 Abr 1999Embol-X Inc.Atherectomy device having trapping and excising means for removal of plaque from the aorta and other arteries
US5910154 *12 Feb 19988 Jun 1999Embol-X, Inc.Percutaneous catheter and guidewire having filter and medical device deployment
US5911734 *8 May 199715 Jun 1999Embol-X, Inc.Percutaneous catheter and guidewire having filter and medical device deployment capabilities
US5916193 *30 Nov 199629 Jun 1999Heartport, Inc.Endovascular cardiac venting catheter and method
US5919163 *14 Jul 19976 Jul 1999Delcath Systems, Inc.Catheter with slidable balloon
US5925016 *27 Sep 199520 Jul 1999Xrt Corp.Systems and methods for drug delivery including treating thrombosis by driving a drug or lytic agent through the thrombus by pressure
US5941896 *16 Dic 199724 Ago 1999Montefiore Hospital And Medical CenterFilter and method for trapping emboli during endovascular procedures
US5997503 *12 Feb 19987 Dic 1999Ballard Medical ProductsCatheter with distally distending balloon
US5997557 *11 Feb 19987 Dic 1999Embol-X, Inc.Methods for aortic atherectomy
US6013085 *7 Nov 199711 Ene 2000Howard; JohnMethod for treating stenosis of the carotid artery
US6022336 *6 Mar 19978 Feb 2000Percusurge, Inc.Catheter system for emboli containment
US6027476 *19 Sep 199722 Feb 2000Heartport, Inc.Methods and systems for performing thoracoscopic coronary bypass and other procedures
US6029671 *22 May 199629 Feb 2000Heartport, Inc.System and methods for performing endovascular procedures
US6042559 *24 Feb 199828 Mar 2000Innercool Therapies, Inc.Insulated catheter for selective organ perfusion
US6056720 *24 Nov 19982 May 2000Embol-X, Inc.Occlusion cannula and methods of use
US6059745 *20 May 19979 May 2000Gelbfish; Gary A.Thrombectomy device and associated method
US6066158 *25 Jul 199623 May 2000Target Therapeutics, Inc.Mechanical clot encasing and removal wire
US6090096 *23 Abr 199718 Jul 2000Heartport, Inc.Antegrade cardioplegia catheter and method
US6099497 *5 Mar 19988 Ago 2000Scimed Life Systems, Inc.Dilatation and stent delivery system for bifurcation lesions
US6120477 *19 May 199719 Sep 2000Gore Enterprise Holdings, Inc.Balloon catheter device
US6126635 *5 Jun 19953 Oct 2000Advanced Cardiovascular Systems, Inc.Adjustable treatment chamber catheter
US6129708 *23 Feb 199910 Oct 2000Medtronic Ave, Inc.Rapidly exchangeable coronary catheter
US6135991 *27 Mar 199824 Oct 2000Percusurge, Inc.Aspiration method
US6161547 *15 Ene 199919 Dic 2000Coaxia, Inc.Medical device for flow augmentation in patients with occlusive cerebrovascular disease and methods of use
US6165199 *12 Ene 199926 Dic 2000Coaxia, Inc.Medical device for removing thromboembolic material from cerebral arteries and methods of use
US6176851 *31 Ago 199923 Ene 2001Embol-X, Inc.Cardioplegia occluder
US6180059 *24 Jul 199830 Ene 2001Therox, Inc.Method for the preparation and delivery of gas-enriched fluids
US6206868 *14 Jun 199927 Mar 2001Arteria Medical Science, Inc.Protective device and method against embolization during treatment of carotid artery disease
US6221042 *17 Sep 199924 Abr 2001Scimed Life Systems, Inc.Balloon with reversed cones
US6228052 *29 Feb 19968 May 2001Medtronic Inc.Dilator for introducer system having injection port
US6238412 *11 Nov 199829 May 2001William DubrulBiological passageway occlusion removal
US6264631 *11 Ago 199924 Jul 2001Ballard Medical ProductsCatheter with distally distending balloon
US6295989 *4 Feb 19982 Oct 2001Arteria Medical Science, Inc.ICA angioplasty with cerebral protection
US6379373 *3 Sep 199930 Abr 2002Confluent Surgical, Inc.Methods and apparatus for intraluminal deposition of hydrogels
US6398752 *5 Jun 19984 Jun 2002William P. Sweezer, Jr.Method of occluding a patient's ascending aorta and delivery cardioplegic fluid
US6413235 *13 May 19982 Jul 2002Arteria Medical Science, Inc.Protective device against embolization in carotid angioplasty
US6423032 *15 Oct 199923 Jul 2002Arteria Medical Science, Inc.Apparatus and methods for reducing embolization during treatment of carotid artery disease
US6458139 *21 Jun 20001 Oct 2002Endovascular Technologies, Inc.Filter/emboli extractor for use in variable sized blood vessels
US6540712 *20 Mar 20001 Abr 2003Arteria Medical Science, Inc.Methods and low profile apparatus for reducing embolization during treatment of carotid artery disease
US20020087119 *16 Nov 20014 Jul 2002Arteria Medical Science, Inc.Apparatus and methods for reducing embolization during treatment of carotid artery disease
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
US934549926 May 201224 May 2016Covidien LpPressure activated foreign body removal system and method of use
US959717111 Sep 201221 Mar 2017Covidien LpRetrieval catheter with expandable tip
CN104688290A *7 Dic 201310 Jun 2015复旦大学附属妇产科医院Method for internal compression hemostasis after minimally invasive breast lump rotary varicotomy and hemostatic balloon
CN106102654A *9 Ene 20159 Nov 2016企斯动哈特有限公司Anatomy independent deflector
Clasificaciones
Clasificación de EE.UU.606/194
Clasificación internacionalA61M29/00, A61F2/01, A61M1/00, A61B17/00, A61B17/12, A61B17/22, A61M29/02
Clasificación cooperativaA61M29/00, A61F2230/0006, A61F2/01, A61M2025/1097, A61B17/12109, A61M2205/75, A61B2017/320716, A61B17/22, A61B2017/00243, A61F2/013, A61M2025/1015, A61B2217/005, A61M2025/109, A61B17/12045, A61B17/12136, A61B2017/22067, A61B17/221, A61M2025/1052, A61M25/104, A61F2002/011, A61B17/12
Clasificación europeaA61F2/01D, A61B17/12, A61B17/12P5B, A61B17/12P1T2, A61B17/12P7B, A61B17/22, A61M25/10P, A61F2/01
Eventos legales
FechaCódigoEventoDescripción
14 Feb 2012ASAssignment
Owner name: W. L. GORE & ASSOCIATES, INC., DELAWARE
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GORE ENTERPRISE HOLDINGS, INC.;REEL/FRAME:027906/0508
Effective date: 20120130